Abstract
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia in the absence of other disorders. Vitamin D (VD) has been shown to modulate the immune system and its deficiency is linked to many immunological disorders. Supplementation with VD in ITP has promising results. This work aims at evaluating VD values in children with persistent and chronic ITP and the effect of its deficiency on disease severity and treatment response. A case–control study including 50 persistent and chronic ITP patients and 50 healthy controls was conducted. 25 OH vitamin D level was determined using ELISA technique. VD median value was significantly higher among the control group than that of the patients’ group (28 vs 21.5 and p = 0.002). Severe deficiency was detected significantly more among the patients’ group than the control group (12 (24%) vs 3 (6%), p = 0.048) respectively. Forty-four percent of complete responders belong to sufficient VD category ((15/34) ~ 44% (p = 0.005)) representing all patients with sufficient VD status (n = 15). Also, a positive correlation between serum level of vitamin D and mean PLT count was observed (r = 0.316, p value = 0.025). Sufficient vitamin D was associated with better treatment response and less disease severity. Vitamin D supplementation may be a new therapeutic option for chronic ITP.
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 3:3829–3866
Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, Fryzek J, Kaye JA (2010) Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol 149(6):855–864
Consolini R, Legitimo A, Caparello MC (2016) The centenary of immune thrombocytopenia–part 1: revising nomenclature and pathogenesis. Front Pediatr 19(4):102
Cooper N (2017) State of the art-how I manage immune thrombocytopenia. Br J Hematol 177(1):39–54
Kim TO, Despotovic JM (2021) Pediatric immune thrombocytopenia (ITP) treatment. Ann Blood 6:4
Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 23:3829–3866
Suntsova EV, Maschan AA, Baydildina DD, Kalinina II, Petrova UN, Pshonkin AV, Novichkova GA (2019) Thrombopoietin receptor agonist switch in children with persistent and chronic severe immune thrombocytopenia: a retrospective analysis in a large tertiary center. Pediatr Blood Cancer 66(6):e27704
Bener A, Ehlayel MS, Bener HZ, Hamid Q (2014) The impact of vitamin D deficiency on asthma, allergic rhinitis and wheezing in children: an emerging public health problem. J Fam Community Med 21(3):154–161
Adorini L (2002) Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2:1017–1028
Zold E, Barta Z, Bodolay E (2011) Vitamin D deficiency and connective tissue disease. Vitam Horm 86:261–286
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood J 113(11):2386–2393
El-Ziny MA, Al-Marsafawy HM, El-Hagar MM, Chalaby NM, El-Sherify EO (2003) Growth parameters and adiposity in Egyptian infants &children. Egypt J Community Med 21:63–73
Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel JB, Cines DB, Cooper N, Godeau B, Greinacher A, Imbach P, Khellaf M, Klaassen RJ, Kühne T, Liebman H, Mazzucconi MG, Newland A, Pabinger I, Tosetto A, Stasi R (2013) Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood 121:2596–2606
Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA (2011) The American Society of Hematology evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190–4207
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930
Saggese G, Vierucci F, Prodam F, Cardinale F, Cetin I, Chiappini E, De’ Angelis GL, Massari M, Miraglia Del Giudice E, Miraglia Del Giudice M et al (2018) Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians. Ital J Pediatr 44:51
Herly M, Stengaard-Pedersen K, Hørslev-Petersen K, Hetland ML, Østergaard M, Christensen R, Løgstrup BB, Vestergaard P, Pødenphant J, Junker P, Ellingsen T (2017) Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes. BMJ Open 7(4):e014816
Berrueco R, Dapena JL, Sebastián E, Sastre A (2018) Controversies in the treatment of pediatric immune thrombocytopenia. Anales de Pediatría (English Edition) 89(3):1–8
Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi G, Bodolay E (2008) Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 10(5):R123
Aranow C (2011) Vitamin D and the immune system. J Investig Med 59(6):881–886
Moulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre-Mestre M, Sailler L (2014) Epidemiology of incident immune thrombocytopenia, a nationwide population–based study in France. Blood 124:3308–3315
Sutor AH, Harms A, Kaufmehl K (2001) Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 27(3):253–267
Fogarty PF, Segal JB (2007) The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol 14(5):515–519
Fattizzo B, Zaninoni A, Giannotta JA, Binda F, Cortelezzi A, Barcellini W (2016) Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review. Autoimmun Rev 15(7):770–775
Kalbassi Z, Shiri H (2014) PO-1017 prevalence of vitamin D deficiency in idiopathic thrombocytopenic purpura (ITP). BMJ J 99:2
Emam FE, El-Wahab TMA, Mohammed MS, Elsalhy AS, Rahem SIA (2014) Assessment of serum vitamin D level in patients with systemic lupus erythematosus. Egypt Rheumatol Rehabil 41(2):71
Petrovic D, Benzon B, Batinic M, Culic S, Roganovic J, Markic J (2019) Hypovitaminosis D influences the clinical presentation of immune thrombocytopenia in children with newly diagnosed disease. J Clin Med 8(11):1861
Neunert C, Noroozi N, Norman G, Buchanan GR, Goy J, Nazi I, Kelton JG, Arnold DM (2015) Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost 13:457–464
Kumar M, Dutta S, Bhattyacharyya M (2015) Application of ITP-BAT bleeding score in clinical practice. Int J Hematol 101:207–208
Arnold DM (2012) Platelet count or bleeding as the outcome in ITP trials? Am J Hematol 87:945–946
Bockow B, Kaplan TB (2013) Refractory immune thrombocytopenia successfully treated with high-dose vitamin D supplementation and hydroxychloroquine: two case reports. J Med Case Rep 7:91
Baro F, Bastin J, Schifflers S, Francotte N, Philippet P, Chantrain CF (2018) Refractory immune thrombocytopenic purpura in a child with vitamin D deficiency. BELG J HEMATOL 9(2):64–67
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in the study were in accordance with the ethical standards of the national institutional review board and with the 1964 Helsinki Declaration and its later amendments. The study was approved by local the institutional review board (code number: MS. 18. 11. 361).
Consent to participate
Written informed consents were obtained from the parents.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mabrouk, R.E., Hussein, D.T., Abbas, M.E.E.R. et al. Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia. Ann Hematol 102, 2033–2038 (2023). https://doi.org/10.1007/s00277-023-05210-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-023-05210-9